Assessment factors--applications in health risk assessment of chemicals.

We review the scientific basis for default assessment factors used in risk assessment of nongenotoxic chemicals including the use of chemical- and pathways specific assessment factors, and extrapolation approaches relevant to species differences, age and gender. One main conclusion is that the conventionally used default factor of 100 does not cover all inter-species and inter-individual differences. We suggest that a species-specific default factor based on allometric scaling should be used for inter-species extrapolation (basal metabolic rate). Regarding toxicodynamic and remaining toxicokinetic differences we suggest that a percentile from a probabilistic distribution is chosen to derive the assessment factor. Based on the scarce information concerning the human-to-human variability it is more difficult to suggest a specific assessment factor. However, extra emphasis should be put on sensitive populations such as neonates and genetically sensitive subgroups, and also fetuses and children which may be particularly vulnerable during development and maturation. Factors that also need to be allowed for are possible gender differences in sensitivity, deficiencies in the databases, nature of the effect, duration of exposure, and route-to-route extrapolation. Since assessment factors are used to compensate for lack of knowledge we feel that it is prudent to adopt a "conservative" approach, erring on the side of protectiveness.

[1]  Lesa L Aylward,et al.  An evaluation of benchmark dose methodology for non-cancer continuous-data health effects in animals due to exposures to dioxin (TCDD). , 2004, Regulatory toxicology and pharmacology : RTP.

[2]  H. Feldman,et al.  The 3/4 mass exponent for energy metabolism is not a statistical artifact. , 1983, Respiration physiology.

[3]  H. Kay Environmental Health Criteria , 1980 .

[4]  M L Dourson,et al.  An Approach for Modeling Noncancer Dose Responses with an Emphasis on Uncertainty , 1997, Risk analysis : an official publication of the Society for Risk Analysis.

[5]  D. Hattis,et al.  Distributions of Individual Susceptibility among Humans for Toxic Effects: How Much Protection Does the Traditional Tenfold Factor Provide for What Fraction of Which Kinds of Chemicals and Effects? , 1999, Annals of the New York Academy of Sciences.

[6]  W. Slob,et al.  Mathematical modelling and quantitative methods. , 2002, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[7]  J. Dorne Impact of inter‐individual differences in drug metabolism and pharmacokinetics on safety evaluation , 2004, Fundamental & clinical pharmacology.

[8]  H J Clewell,et al.  Incorporation of pharmacokinetics in noncancer risk assessment: example with chloropentafluorobenzene. , 1994, Risk analysis : an official publication of the Society for Risk Analysis.

[9]  Monique A J Rennen,et al.  Oral-to-inhalation route extrapolation in occupational health risk assessment: a critical assessment. , 2004, Regulatory toxicology and pharmacology : RTP.

[10]  E J Calabrese,et al.  Uncertainty factors and interindividual variation. , 1985, Regulatory toxicology and pharmacology : RTP.

[11]  W Slob,et al.  Assessment factors for human health risk assessment: a discussion paper. , 1999, Critical reviews in toxicology.

[12]  E. Mark,et al.  Polymorphisms in the Dna Repair Genes Xrcc1 and Ercc2 and Biomarkers of Dna Damage in Human Blood Mononuclear Cells Cross-complementing Group 1) than in 399arg/arg Carriers of Breaks following Base Excision Repair (ber) Resulting From , 2022 .

[13]  B. Weiss Sexually dimorphic nonreproductive behaviors as indicators of endocrine disruption. , 2002, Environmental health perspectives.

[14]  J. Sastre,et al.  Mitochondria from females exhibit higher antioxidant gene expression and lower oxidative damage than males. , 2003, Free radical biology & medicine.

[15]  K Walton,et al.  Uncertainty factors for chemical risk assessment: interspecies differences in the in vivo pharmacokinetics and metabolism of human CYP1A2 substrates. , 2001, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[16]  R. Parshad,et al.  XPD polymorphisms: effects on DNA repair proficiency. , 2000, Carcinogenesis.

[17]  J. Yokota,et al.  Genetic polymorphisms and alternative splicing of the hOGG1 gene, that is involved in the repair of 8-hydroxyguanine in damaged DNA , 1998, Oncogene.

[18]  S G Selevan,et al.  Identifying critical windows of exposure for children's health. , 2000, Environmental health perspectives.

[19]  Wout Slob,et al.  A comparison of ratio distributions based on the NOAEL and the benchmark approach for subchronic-to-chronic extrapolation. , 2005, Toxicological sciences : an official journal of the Society of Toxicology.

[20]  Salomon Sand,et al.  Evaluation of the benchmark dose method for dichotomous data: model dependence and model selection. , 2002, Regulatory toxicology and pharmacology : RTP.

[21]  A. Dirksen,et al.  Incidence of allergic contact sensitization in Danish adults between 1990 and 1998; the Copenhagen Allergy Study, Denmark , 2002, The British journal of dermatology.

[22]  Michael Dourson,et al.  Differential sensitivity of children and adults to chemical toxicity. I. Biological basis. , 2002, Regulatory toxicology and pharmacology : RTP.

[23]  Salomon Sand,et al.  The Benchmark Dose Method—Review of Available Models, and Recommendations for Application in Health Risk Assessment , 2003, Critical reviews in toxicology.

[24]  R. Menne Textbook of Contact Dermatitis , 1995, Springer Berlin Heidelberg.

[25]  K Walton,et al.  Species-specific uncertainty factors for compounds eliminated principally by renal excretion in humans. , 2004, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[26]  D Krewski,et al.  Procedures for calculating benchmark doses for health risk assessment. , 1998, Regulatory toxicology and pharmacology : RTP.

[27]  D Hattis,et al.  Human variability in susceptibility to toxic chemicals--a preliminary analysis of pharmacokinetic data from normal volunteers. , 1987, Risk analysis : an official publication of the Society for Risk Analysis.

[28]  M. Abdel‐Rahman,et al.  Evaluation of the use of uncertainty factors in deriving RfDs for some chlorinated compounds. , 1995, Journal of toxicology and environmental health.

[29]  U. Tillmann,et al.  A systematic approach for evaluating the quality of experimental toxicological and ecotoxicological data. , 1997, Regulatory toxicology and pharmacology : RTP.

[30]  G. Coetzee,et al.  Isothiocyanates, glutathione S-transferase M1 and T1 polymorphisms, and lung-cancer risk: a prospective study of men in Shanghai, China , 2000, The Lancet.

[31]  F P Perera,et al.  Molecular epidemiology: insights into cancer susceptibility, risk assessment, and prevention. , 1996, Journal of the National Cancer Institute.

[32]  A G Renwick,et al.  Toxicokinetics in infants and children in relation to the ADI and TDI. , 1998, Food additives and contaminants.

[33]  D W Gaylor,et al.  Issues in qualitative and quantitative risk analysis for developmental toxicology. , 1988, Risk analysis : an official publication of the Society for Risk Analysis.

[34]  M. Spitz,et al.  Ethnic differences in the prevalence of the homozygous deleted genotype of glutathione S-transferase theta. , 1995, Carcinogenesis.

[35]  K Walton,et al.  Human variability in xenobiotic metabolism and pathway-related uncertainty factors for chemical risk assessment: a review. , 2005, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[36]  M L Dourson,et al.  Regulatory history and experimental support of uncertainty (safety) factors. , 1983, Regulatory toxicology and pharmacology : RTP.

[37]  R. Garnier,et al.  Glutathione transferase activity and formation of macromolecular adducts in two cases of acute methyl bromide poisoning. , 1996, Occupational and environmental medicine.

[38]  K. Schneider,et al.  Allometric principles for interspecies extrapolation in toxicological risk assessment--empirical investigations. , 2004, Regulatory toxicology and pharmacology : RTP.

[39]  K S Crump,et al.  A new method for determining allowable daily intakes. , 1984, Fundamental and applied toxicology : official journal of the Society of Toxicology.

[40]  Wout Slob,et al.  Dose-response modeling of continuous endpoints. , 2002, Toxicological sciences : an official journal of the Society of Toxicology.

[41]  V. Ribeiro,et al.  CYP3A4*1B and NAT2*14 Alleles in a Native African Population , 2003, Clinical chemistry and laboratory medicine.

[42]  K. Richert-Boe,et al.  Glutathione S-transferase M1 (GSTM1) deficiency and lung cancer risk. , 1995, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[43]  Xi,et al.  Benzene poisoning, a risk factor for hematological malignancy, is associated with the NQO1 609C-->T mutation and rapid fractional excretion of chlorzoxazone. , 1997, Cancer research.

[44]  Derek J. Knight,et al.  Annex: Directive 98/8/EC of the European Parliament and of the Council of 16 February 1998 Concerning the Placing of Biocidal Products on the Market , 2002 .

[45]  K Walton,et al.  Uncertainty factors for chemical risk assessment. human variability in the pharmacokinetics of CYP1A2 probe substrates. , 2001, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[46]  Michael Dourson,et al.  A Probabilistic Framework for the Reference Dose (Probabilistic RfD) , 1998 .

[47]  M. Brockhaus,et al.  The effects of β-estradiol on SHSY5Y neuroblastoma cells during heavy metal induced oxidative stress, neurotoxicity and β-amyloid secretion , 2002, Neuroscience.

[48]  S. Bonenfant,et al.  How is sex considered in recent epidemiological publications on occupational risks? , 2000, Occupational and environmental medicine.

[49]  A. Renwick Data-derived safety factors for the evaluation of food additives and environmental contaminants. , 1993, Food additives and contaminants.

[50]  E. Silbergeld,et al.  Chemicals and menopause: effects on age at menopause and on health status in the postmenopausal period. , 1999, Journal of women's health.

[51]  Harvey J Clewell,et al.  Evaluation of the potential impact of age- and gender-specific pharmacokinetic differences on tissue dosimetry. , 2004, Toxicological sciences : an official journal of the Society of Toxicology.

[52]  C. Kimmel,et al.  Dose-response assessment for developmental toxicity. II. Comparison of generic benchmark dose estimates with no observed adverse effect levels. , 1994, Fundamental and applied toxicology : official journal of the Society of Toxicology.

[53]  M. Pieters,et al.  Evaluation of the uncertainty factor for subchronic-to-chronic extrapolation: statistical analysis of toxicity data. , 1998, Regulatory toxicology and pharmacology : RTP.

[54]  Edward V. Sargent,et al.  Use of toxicokinetic and toxicodynamic data to reduce uncertainties when setting occupational exposure limits for pharmaceuticals , 1997 .

[55]  A G Renwick,et al.  Safety factors and establishment of acceptable daily intakes. , 1991, Food additives and contaminants.

[56]  Kenny S. Crump,et al.  Calculation of Benchmark Doses from Continuous Data , 1995 .

[57]  J. Dorne,et al.  Human variability in the renal elimination of foreign compounds and renal excretion-related uncertainty factors for risk assessment. , 2004, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[58]  J. Dorne,et al.  Uncertainty factors for chemical risk assessment: interspecies differences in glucuronidation. , 2001, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[59]  J. Dorne,et al.  Human variability in CYP3A4 metabolism and CYP3A4-related uncertainty factors for risk assessment. , 2003, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[60]  Magnus Ingelman-Sundberg,et al.  Pharmacogenetics of cytochrome P450 and its applications in drug therapy: the past, present and future. , 2004, Trends in pharmacological sciences.

[61]  M L Dourson,et al.  Evolution of science-based uncertainty factors in noncancer risk assessment. , 1996, Regulatory toxicology and pharmacology : RTP.

[62]  L. Tuxen,et al.  Integrated risk information system (IRIS) , 1990 .

[63]  K Walton,et al.  Human variability in polymorphic CYP2D6 metabolism: is the kinetic default uncertainty factor adequate? , 2002, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[64]  D. Hattis,et al.  Evaluation of child/adult pharmacokinetic differences from a database derived from the therapeutic drug literature. , 2002, Toxicological sciences : an official journal of the Society of Toxicology.

[65]  W. Slob,et al.  A Probabilistic Approach for Deriving Acceptable Human Intake Limits and Human Health Risks from Toxicological Studies: General Framework , 1998 .

[66]  Ulrike Schuhmacher-Wolz,et al.  Uncertainty in toxicological risk assessment for non-carcinogenic health effects. , 2003, Regulatory toxicology and pharmacology : RTP.

[67]  D. Hattis,et al.  Differences in Pharmacokinetics Between Children and Adults—II. Children's Variability in Drug Elimination Half‐Lives and in Some Parameters Needed for Physiologically‐Based Pharmacokinetic Modeling , 2003, Risk analysis : an official publication of the Society for Risk Analysis.

[68]  R L Kodell,et al.  Upper confidence limits on excess risk for quantitative responses. , 1993, Risk analysis : an official publication of the Society for Risk Analysis.

[69]  J. Dorne,et al.  Polymorphic CYP2C19 and N-acetylation: human variability in kinetics and pathway-related uncertainty factors. , 2003, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[70]  J. Brent,et al.  Derivation of a chemical-specific adjustment factor (CSAF) for use in the assessment of risk from chronic exposure to ethylene glycol: application of International Programme for Chemical Safety guidelines. , 2005, Toxicology and applied pharmacology.

[71]  W Slikker,et al.  Risk assessment for neurotoxic effects. , 1990, Neurotoxicology.

[72]  Agneta Falk Filipsson,et al.  Benchmark Calculations in Risk Assessment Using Continuous Dose‐Response Information: The Influence of Variance and the Determination of a Cut‐Off Value , 2003, Risk analysis : an official publication of the Society for Risk Analysis.

[73]  K Walton,et al.  Human variability for metabolic pathways with limited data (CYP2A6, CYP2C9, CYP2E1, ADH, esterases, glycine and sulphate conjugation). , 2004, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[74]  S. Ekman,et al.  Metabolism of human cytochrome P450 marker substrates in mouse: a strain and gender comparison , 2004, Xenobiotica; the fate of foreign compounds in biological systems.

[75]  A G Renwick,et al.  Human variability and noncancer risk assessment--an analysis of the default uncertainty factor. , 1998, Regulatory toxicology and pharmacology : RTP.

[76]  David E. Burmaster,et al.  Human Interindividual Variability in Parameters Related to Health Risks , 1999, Risk analysis : an official publication of the Society for Risk Analysis.

[77]  O. G. Fitzhugh,et al.  100-Fold margin of safety , 1954 .

[78]  K Walton,et al.  An analysis of the need for an additional uncertainty factor for infants and children. , 2000, Regulatory toxicology and pharmacology : RTP.

[79]  J. Dorne,et al.  Human variability in glucuronidation in relation to uncertainty factors for risk assessment. , 2001, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.